These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7865827)

  • 21. Affinity purification of a high molecular weight human breast cancer-associated antigen identified by the BCD-B4 monoclonal antibody.
    Mandeville R; Dumas F; Amarouch A; Sidrac-Ghali S; Walker MC; Zelechowska M; Ajdukovic I; Grouix B
    Hybridoma; 1987 Oct; 6(5):441-51. PubMed ID: 3679257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucins in breast cancer: recent immunological advances.
    McKenzie IF; Xing PX
    Cancer Cells; 1990 Mar; 2(3):75-8. PubMed ID: 2202380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C595--a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas.
    Price MR; Pugh JA; Hudecz F; Griffiths W; Jacobs E; Symonds IM; Clarke AJ; Chan WC; Baldwin RW
    Br J Cancer; 1990 May; 61(5):681-6. PubMed ID: 1692469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The identification and development of specific monoclonal antibodies to squamous cell carcinoma.
    Arlen M; Tsang A; Scherrer J; Wolf J; Saric O
    Crit Rev Immunol; 2001; 21(1-3):205-14. PubMed ID: 11642605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of anti-sialyl-Tn antibodies in patients with colorectal and breast cancer.
    Coomber DW; Hawkins NJ; Dalley D; Ward RL
    Neoplasma; 1998; 45(1):12-6. PubMed ID: 9604995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicochemical purification and immunological characteristics of ductal carcinoma antigen.
    Papsidero LD; Johnson EA
    Int J Cancer; 1986 May; 37(5):697-703. PubMed ID: 2422128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucinic tumor markers recognized by monoclonal antibodies.
    Seregni E; Bombardieri E; Maffioli L; Buraggi GL
    J Nucl Med Allied Sci; 1990; 34(4):314-20. PubMed ID: 2090797
    [No Abstract]   [Full Text] [Related]  

  • 28. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
    Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W
    Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemistry and molecular biology of MCA.
    Maurer A; Burckhardt J
    Int J Biol Markers; 1993; 8(2):108-12. PubMed ID: 8366293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A short synthetic peptide (DTRPAP) induces anti-mucin (MUC-1) antibody, which is reactive with human ovarian and breast cancer cells.
    Avichezer D; Taylor-Papadimitriou J; Arnon R
    Cancer Biochem Biophys; 1998 Jun; 16(1-2):113-28. PubMed ID: 9923971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on immune response of human lung cancer by cell surface antigen].
    Shimada K; Yasuda S
    Rinsho Kyobu Geka; 1984 Jan; 4(1):53-60. PubMed ID: 6377454
    [No Abstract]   [Full Text] [Related]  

  • 33. Human models of breast cancer.
    Taylor-Papadimitriou J; Berdichevsky F; D'Souza B; Burchell J
    Cancer Surv; 1993; 16():59-78. PubMed ID: 8348539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antigens associated with human breast carcinoma].
    Kriukova IN; Vasilevskaia LN
    Vopr Onkol; 1975; 21(2):52-6. PubMed ID: 805495
    [No Abstract]   [Full Text] [Related]  

  • 36. Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes.
    Rohrer JW; Barsoum AL; Dyess DL; Tucker JA; Coggin JH
    J Immunol; 1999 Jun; 162(11):6880-92. PubMed ID: 10352310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.
    Freire T; Bay S; von Mensdorff-Pouilly S; Osinaga E
    Cancer Res; 2005 Sep; 65(17):7880-7. PubMed ID: 16140958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies reactive with mucin expressed in breast cancer.
    Xing PX; Tjandra JJ; Stacker SA; Teh JG; Thompson CH; McLaughlin PJ; McKenzie IF
    Immunol Cell Biol; 1989 Jun; 67 ( Pt 3)():183-95. PubMed ID: 2477330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-tumor activity and immune responses induced by human cancer-associated mucin core peptide].
    Ma Y; Yuan M; Fei L
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):419-21. PubMed ID: 9387291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of mucin-associated carbohydrate core antigens in esophageal squamous cell carcinomas.
    Flucke U; Zirbes TK; Schröder W; Mönig SP; Koch V; Schmitz K; Thiele J; Dienes HP; Hölscher AH; Baldus SE
    Anticancer Res; 2001; 21(3C):2189-93. PubMed ID: 11501845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.